tiprankstipranks
BridgeBio Pharma Inc (DE:2CL)
XETRA:2CL
Germany Market
2CL
BridgeBio Pharma
RESEARCH TOOLSreports

BridgeBio Pharma (2CL) Balance Sheet

3 Followers

BridgeBio Pharma Balance Sheet

BridgeBio Pharma's total assets for Q2 2026 were $1.22B, a decrease of -11.21% from the previous quarter. DE:2CL total liabilities were $3.72B for the fiscal quarter, a 2.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 936.02M$ 919.34M$ 546.38M$ 623.04M$ 1.01B
Total Liabilities
$ 3.01B$ 2.38B$ 1.89B$ 1.87B$ 1.88B
Total Equity Gross Minority
$ -2.08B$ -1.46B$ -1.34B$ -1.24B$ -865.58M
Other Metrics
Currency in USD

BridgeBio Pharma Debt to Assets